Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-26,448
Closed -$39.9K 3487
2026
Q1
$39.9K Hold
26,448
﹤0.01% 3429
2025
Q4
$56.9K Buy
26,448
+14,388
+119% +$49.1K ﹤0.01% 3420
2025
Q3
$58.1K Hold
12,060
﹤0.01% 3421
2025
Q2
$66.9K Sell
12,060
-3,311
-22% -$26.2K ﹤0.01% 3433
2025
Q1
$189K Hold
15,371
﹤0.01% 3266
2024
Q4
$206K Hold
15,371
﹤0.01% 3324
2024
Q3
$144K Hold
15,371
﹤0.01% 3360
2024
Q2
$149K Buy
15,371
+3,099
+25% +$30.7K ﹤0.01% 3457
2024
Q1
$129K Hold
12,272
﹤0.01% 3284
2023
Q4
$164K Hold
12,272
﹤0.01% 3301
2023
Q3
$178K Hold
12,272
﹤0.01% 3305
2023
Q2
$242K Buy
+12,272
New +$193K ﹤0.01% 3281
2022
Q1
Sell
-2,412
Closed -$138K 3599
2021
Q4
$138K Buy
2,412
+32
+1% +$2.14K ﹤0.01% 3409
2021
Q3
$180K Sell
2,380
-14,279
-86% -$1.51M ﹤0.01% 3340
2021
Q2
$2.8M Buy
16,659
+3,123
+23% +$547K ﹤0.01% 2609
2021
Q1
$2.37M Buy
13,536
+354
+3% +$71.4K ﹤0.01% 2614
2020
Q4
$2.7M Buy
13,182
+434
+3% +$80.6K ﹤0.01% 2513
2020
Q3
$2.49M Buy
+12,748
New +$3.07M ﹤0.01% 2422

Other funds holding GOCO

Charles Schwab's GOCO Position: Q2 2026 in Review

Charles Schwab sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 26,448 shares — an estimated $39.9K sold.

Charles Schwab first reported a position in GOCO in Q3 2020 and held it in 18 quarters. The position peaked at $2.8M in Q2 2021. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Charles Schwab reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Charles Schwab sold 26,448 GoHealth shares in Q2 2026, an estimated $39.9K.
  • Charles Schwab first reported a position in GoHealth in Q3 2020 and held it in 18 quarters.
  • Charles Schwab's GoHealth position peaked at $2.8M in Q2 2021.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.